Qianjun Chen
Impact in
-
- Breast Cancer Treatment Studies
Papers in
- Oncology 19
- HER2/EGFR in Cancer Research 7
- Cancer Treatment and Pharmacology 5
- Cancer Cells and Metastasis 3
-
- Advanced Breast Cancer Therapies 9
- Co-authors
- Zhengmeng Hou (5 shared papers)Xuning Wu (4 shared papers)Lin Wu (4 shared papers)Honglin Situ (3 shared papers)Pengxi Liu (3 shared papers)Zhifeng Luo (3 shared papers)Zhiyu Wang (3 shared papers)Neng Wang (2 shared papers)
In The Last Decade
Qianjun Chen
45 papers receiving 518 citations
Peers
Comparison fields: 5 of 110
- Cancer Research 102
- Complementary and alternative medicine 50
- Oncology 133
- Cell Biology 70
- Energy Engineering and Power Technology 11
Countries citing papers authored by Qianjun Chen
This map shows the geographic impact of Qianjun Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qianjun Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qianjun Chen more than expected).
Fields of papers citing papers by Qianjun Chen
This network shows the impact of papers produced by Qianjun Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qianjun Chen. The network helps show where Qianjun Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Qianjun Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 75 | |
| 2 | 2018 | 58 | |
| 3 | 2015 | 47 | |
| 4 | 2022 | 44 | |
| 5 | 2023 | 39 | |
| 6 | 2021 | 30 | |
| 7 | 2023 | 24 | |
| 8 | 2023 | 24 | |
| 9 | 2020 | 14 | |
| 10 | 2019 | 13 | |
| 11 | 2015 | 13 | |
| 12 | 2023 | 12 | |
| 13 | 2021 | 12 | |
| 14 | 2021 | 11 | |
| 15 | 2021 | 9 | |
| 16 | 2024 | 8 | |
| 17 | 2023 | 7 | |
| 18 | 2023 | 7 | |
| 19 | 2022 | 7 | |
| 20 | 2023 | 6 |
About Qianjun Chen
Qianjun Chen is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research and Genetics, having authored 50 papers that have together received 529 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (9 papers), HER2/EGFR in Cancer Research (7 papers), Cancer Treatment and Pharmacology (5 papers), Breast Cancer Treatment Studies (5 papers), Chronic Lymphocytic Leukemia Research (4 papers), Cancer, Stress, Anesthesia, and Immune Response (4 papers), Traditional Chinese Medicine Studies (4 papers) and Cancer Cells and Metastasis (3 papers). The work is most often cited by research in Cancer Research (102 citations), Complementary and alternative medicine (50 citations), Oncology (133 citations), Cell Biology (70 citations) and Energy Engineering and Power Technology (11 citations). Qianjun Chen has collaborated with scholars based in China, Germany and Australia. Frequent co-authors include Zhengmeng Hou, Xuning Wu, Lin Wu, Honglin Situ, Pengxi Liu, Zhifeng Luo, Zhiyu Wang, Neng Wang, Yi Lin and Wenqiang Liu. Their work appears in journals such as Journal of Clinical Oncology, Frontiers in Oncology, Annals of Translational Medicine, Oncotarget and Integrative Cancer Therapies.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.